市场调查报告书
商品编码
1489436
到 2030 年食品诊断市场预测:按类型、测试类型、诊断系统、地点、污染物类型、应用和地区进行的全球分析Food Diagnostics Market Forecasts to 2030 - Global Analysis By Type (Systems, Consumables and Other Types), Testing Type (Safety and Quality), Diagnostics System, Site, Contaminant Type, Application and by Geography |
根据 Stratistics MRC 的数据,2023 年全球食品诊断市场规模为 165 亿美元,预计在预测期内将以 9.70% 的复合年增长率增长,到 2030 年达到 315.5 亿美元。
为了确保食品安全和质量,食品诊断是一个重要领域,涉及食品中污染物、病原体和其他物质的检测和分析。利用 DNA 分析、层析法和光谱等先进方法,研究人员可以检测过敏原、农药、细菌和毒素等可能的危害。此外,快速、准确的食品诊断对于避免食品感染疾病、确保法规遵循和保护公众健康至关重要。
据美国心臟协会称,定期运动有助于控制血脂、血压和体重,预防心臟病、中风、糖尿病和某些癌症,增强骨骼和肌肉,改善心理健康,提高幸福感。
食物中毒事件呈上升趋势
随着世界人口的成长和都市化,食品和加工食品的消费量不断增加。不幸的是,这种趋势也增加了细菌、病毒和寄生虫等病原体污染食品而导致食源性疾病的发生率。此外,现在比以往任何时候都更需要高效的食品诊断解决方案,以便在受污染的商品出售给客户之前识别并减少可能的风险。
尖端诊断工具成本高
虽然技术进步正在创造日益复杂和精确的食品诊断技术,但这些尖端工具通常价格昂贵。对于小型食品公司和实验室来说,实施先进诊断设备和系统所需的初始投资可能令人望而却步。此外,由于持续维护、校准和培训成本等额外的财务负担,这些技术尚未被广泛采用,特别是在新兴经济体和小型食品企业中。
新兴市场和食品产业的快速发展
由于都市化、人口成长和消费者偏好变化等多种因素,食品工业正在世界各地迅速扩张。亚太地区、拉丁美洲和非洲是食品诊断产业具有巨大成长潜力的新兴市场。此外,这些地区的经济成长和都市化正在增加食品的需求,因此需要强有力的食品安全和品质保证解决方案。
市场进入障碍和监管合规性
由于监管机构执行严格的法规和标准,食品诊断公司在扩大业务和进入新市场方面面临挑战。食品製造商和诊断服务提供者因遵守不断变化的法律规范(包括食品安全、品质标准和标籤要求)而承受巨大的财务和资源成本。此外,由于不同地区和国家的监管要求不同且不一致,国际贸易和市场进入变得更加复杂。
食品诊断市场受到了 COVID-19 大流行的各种影响。一方面,对食品安全和卫生的日益重视增加了对诊断工具的需求,以确保食品品质和安全。监管机构、食品製造商和食品加工商正在加强测试和监测计划,以识别可能的污染物并阻止病毒透过食品传播。然而,疫情扰乱了供应链,导致物流问题、劳动力短缺和生产延误,从而影响了食品诊断用品和服务的可用性和可及性。
基于免疫检测的细分市场预计将在预测期内成为最大的细分市场
食品诊断市场预计将由基于免疫检测的诊断领域主导。基于免疫检测的技术依赖抗体与目标分析物的特异性结合,在食品安全实验室和食品生产设施的常规测试中很普及。其他优点包括高灵敏度、快速结果和易于使用。基于免疫测量的套件和平台广泛用于筛检食品中的各种危害,包括微生物病原体、毒素、农药和过敏原。
预计病原体产业在预测期内复合年增长率最高
食品诊断市场的病原体诊断部分预计将以最高复合年增长率成长。病原体诊断的作用是检测可能导致经由食物传染疾病的危险细菌、病毒和寄生虫,对于维护食品安全至关重要。食物中毒患者数量的增加以及对食品安全的日益关注增加了对快速、准确检测食品中病原体的方法的需求。此外,由于次世代定序(NGS)、免疫测量和聚合酵素链锁反应(PCR)等先进的分子诊断技术,病原体检测正在经历一场革命,比传统的基于培养的方法具有更高的灵敏度、特异性和速度。
食品诊断市场由北美主导。该地区的主导地位归因于多种因素,包括重要的市场参与者和研究机构的存在、严格的食品安全法规以及先进的医疗基础设施。美国农业部 (USDA) 和食品药物管理局(FDA) 制定了严格的标准和法规来确保食品安全和质量,这推动了对先进食品诊断技术的需求。此外,食源性疾病发生率的上升和消费者食品安全意识的提高也推动了该地区先进诊断解决方案的采用。
食品诊断市场正以亚太地区最高的复合年增长率成长。推动这一成长的因素有很多,包括人口扩张、快速都市化、可支配收入增加以及食品安全法的变化。随着消费者健康意识的增强并要求更安全的食品,对强大的食品诊断解决方案的需求日益增长,以确保整个供应链的食品安全和品质。此外,该地区食品加工业的成长、食品贸易的全球化以及食源性疾病的增加正在推动先进诊断技术的采用。
According to Stratistics MRC, the Global Food Diagnostics Market is accounted for $16.50 billion in 2023 and is expected to reach $31.55 billion by 2030 growing at a CAGR of 9.70% during the forecast period. In order to guarantee food products' safety and quality, food diagnostics is an important field that involves the detection and analysis of contaminants, pathogens, and other substances in food products. By utilizing sophisticated methods like DNA analysis, chromatography, and spectroscopy, researchers can detect possible dangers such as allergens, pesticides, bacteria, and toxins. Moreover, quick and precise food diagnostics are essential for avoiding food borne infections, upholding legal compliance, and protecting the general public's health.
According to the American Heart Association, Regular physical activity helps control blood lipids, blood pressure, and weight; prevents heart disease, stroke, diabetes, and some types of cancer; strengthens bones and muscles and improves psychological well-being.
Growing number of food borne illnesses
The consumption of packaged and processed foods has increased in tandem with the growth in the world's population and urbanization. Unfortunately, as a result of pathogens like bacteria, viruses, and parasites contaminating food products, this trend has also increased the frequency of foodborne illnesses. Additionally, as a result, there is a greater need than ever for efficient food diagnostic solutions to recognize and reduce possible hazards before tainted goods are sold to customers.
High expenses of cutting-edge diagnostic tools
While improvements in technology have resulted in the creation of increasingly complex and precise food diagnostic techniques, these state-of-the-art tools are frequently expensive. Smaller food businesses and laboratories may find it prohibitive to make the initial investment necessary for acquiring and implementing advanced diagnostic equipment and systems. Furthermore, these technologies are not widely adopted, especially in emerging economies and small-scale food enterprises, due to additional financial burdens such as ongoing maintenance, calibration, and training costs.
Rapid development in emerging markets and the food sector
The food industry is expanding rapidly worldwide due to various factors like urbanization, population growth, and shifting consumer preferences. Asia-Pacific, Latin America, and Africa are among the emerging markets that offer substantial potential for the food diagnostics industry to grow. Moreover, strong food safety and quality assurance solutions are required as these areas experience economic growth and urbanization due to the rising demand for packaged and processed foods.
Barriers to market access and regulatory compliance
Food diagnostic companies face challenges in expanding their operations and entering new markets due to strict regulations and standards enforced by regulatory bodies. Food manufacturers and diagnostic service providers bear heavy financial and resource costs as a result of complying with various and changing regulatory frameworks, such as those pertaining to food safety, quality standards, and labeling requirements. Additionally, international trade and market access are further complicated by regional and national regulatory requirements that differ and are inconsistent.
The food diagnostics market has been impacted by the COVID-19 pandemic in a number of ways. On the one hand, there is a greater need for diagnostic tools to guarantee the quality and safety of food products due to the growing emphasis on food safety and hygiene. Regulatory bodies, food producers, and food processors have stepped up testing and observation programs to find possible contaminants and stop the virus from spreading through food. However, the pandemic has caused supply chain disruptions, which have impacted the availability and accessibility of food diagnostic goods and services by creating logistical problems, a labor shortage, and production delays.
The Immunoassay Based segment is expected to be the largest during the forecast period
The market for food diagnostics is expected to be dominated by the immunoassay-based diagnostics segment. Immunoassay-based techniques, which rely on the specific binding of antibodies to target analytes, are popular for routine testing in food safety laboratories and food production facilities. Furthermore, they offer advantages like high sensitivity, rapid results, and ease of use. Immunoassay-based kits and platforms are widely used for screening food products for various hazards, including microbial pathogens, toxins, pesticides, and allergens.
The Pathogens segment is expected to have the highest CAGR during the forecast period
The food diagnostics market's pathogen diagnostics segment is projected to grow at the highest CAGR. Detecting dangerous bacteria, viruses, and parasites that can lead to food borne illnesses is what pathogen diagnostics do, and it is essential to maintaining food safety. The need for quick and precise ways to find pathogens in food products has increased due to the rise in foodborne illness cases and growing worries about food safety. Moreover, pathogen detection has undergone a revolution thanks to advanced molecular diagnostic techniques like Next-Generation Sequencing (NGS), immunoassays, and polymerase chain reaction (PCR), which offers higher sensitivity, specificity, and speed than conventional culture-based methods.
The market for food diagnostics is dominated by North America. The region's dominance is ascribed to multiple factors, such as the existence of important market players and research institutions, strict regulations pertaining to food safety, and sophisticated healthcare infrastructure. The United States Department of Agriculture (USDA) and the Food and Drug Administration (FDA) enforce strict standards and regulations to guarantee the safety and quality of food products, which fuels the demand for advanced food diagnostic technologies. Additionally, the adoption of advanced diagnostic solutions in the region has also been fueled by rising foodborne illness incidence and heightened consumer awareness of food safety.
The market for food diagnostics is growing at the highest CAGR in the Asia-Pacific region. Numerous factors are driving this growth, such as population expansion, fast urbanization, rising disposable incomes, and changing food safety laws. Robust food diagnostic solutions are becoming increasingly necessary to guarantee food safety and quality throughout the supply chain as consumers become more health-conscious and demand safer food products. Furthermore, the region's adoption of advanced diagnostic technologies is being propelled by the growth of the food processing industry, the globalization of food trade, and the increasing prevalence of foodborne illnesses.
Key players in the market
Some of the key players in Food Diagnostics market include Biomerieux Sa, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, 3M Company, Randox Food Diagnostics, Shimadzu Corporation, Bio-Rad Laboratories, Inc., Neogen Corporation, Ring Biotechnology Co Ltd., Agilent Technologies Inc., Nemis Technologies AG, Clear Labs, Inc., PerkinElmer Inc. and Biorex Food Diagnostics.
In April 2024, Merck KGaA Darmstadt, Germany entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds. Ompenaclid is currently being evaluated in a Phase II study for the second-line treatment of RAS-mutated (RASmut) advanced or metastatic colorectal cancer (mCRC).
In October 2023, To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targeted cancer treatments, Thermo Fisher Scientific today announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.
In August 2023, Science and medical technology firm Danaher announced that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays. Under the agreement, Danaher will acquire all outstanding Abcam shares for $24 per share in cash, with a total enterprise value of approximately $5.7 billion, including Abcam's assumed debts and net of acquired cash.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.